Search research articles
Contact Us
Filters
Showing results (461-470 of 643) with videos related to
Page
of 65
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Katherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Cancer Cell
|
March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
Chaoyang Sun, Jun Yin, Yong Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2024
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
Aditya Bardia, Ian E Krop, Takahiro Kogawa, et al.
Investigational New Drugs
|
September 25, 2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Oncotarget
|
April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas
Roman Groisberg, David S Hong, Vijaykumar Holla, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Mouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.
Journal for Immunotherapy of Cancer
|
June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancers
David S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
NPJ Precision Oncology
|
July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Page
of 65
Search research articles
Search
Showing results (461-470 of 643) with videos related to
Sort By:
Page
of 65
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Katherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Cancer Cell
|
March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
Chaoyang Sun, Jun Yin, Yong Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2024
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
Aditya Bardia, Ian E Krop, Takahiro Kogawa, et al.
Investigational New Drugs
|
September 25, 2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Oncotarget
|
April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas
Roman Groisberg, David S Hong, Vijaykumar Holla, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2019
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Mouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, et al.
Journal for Immunotherapy of Cancer
|
June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancers
David S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
NPJ Precision Oncology
|
July 31, 2024
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Page
of 65